| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 49.50× | 49.50× | 32.28× | 15.99× | 81.60× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 0.02× | 0.02× | 0.03× | 0.12× | 0.02× | ||
| −0.82× | −0.82× | 4.33× | 0.60× | 0.13× | ||
| −1.05× | −1.05× | 3.46× | 0.51× | 0.12× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/06/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 81.60 | 15.99 | 32.28 | 49.50 | 49.50 | |
| Asset Turnover | 0.02 | 0.12 | 0.03 | 0.02 | 0.02 | |
| Cash Conversion (CFO/Net Income) | 0.13 | 0.60 | 4.33 | -0.82 | -0.82 | |
| CFO/EBITDA | 0.12 | 0.51 | 3.46 | -1.05 | -1.05 |